Idorsia conducts clinical trials globally to advance its studies. Our key assets have the potential to transform treatment in the target indications.
Currently, we support Idorsia activities and clinical studies out of the following locations:
Currently, we support Idorsia activities and clinical studies out of the following locations:
Headquarters of Idorsia Ltd. Responsible for drug discovery, development, registration, production, quality assurance, safety, as well as company management and coordination.
Based in Lörrach, Germany, performs clinical development on behalf of Idorsia and acts as Idorsia's representative for obtaining regulatory approvals in the EU.
Based in Radnor, Pennsylvania, US – is responsible for the commercial operations in the US.
Based in New Jersey, US – performs clinical development on behalf of Idorsia.
Based in Shanghai, PRC – performs research and development on behalf of Idorsia.
Based in Tokyo, Japan – performs clinical development and commercial activities on behalf of Idorsia.
A 100% subsidiary of Idorsia Ltd, based in Berlin, Germany – discovers and develops synthetic carbohydrate vaccines to prevent infection.